Firestone Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Firestone Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-250	Closed	-$10K	–	264
2021 Q3	$10K	Hold	250	–	–	﹤0.01%	366
2021 Q2	$10K	Hold	250	–	–	﹤0.01%	358
2021 Q1	$11K	Hold	250	–	–	﹤0.01%	354
2020 Q4	$14K	Hold	250	–	–	0.01%	328
2020 Q3	$12K	Hold	250	–	–	0.01%	308
2020 Q2	$15K	Hold	250	–	–	0.01%	287
2020 Q1	$12K	Hold	250	–	–	0.01%	293
2019 Q4	$15K	Buy	+250	New	+$14.9K	0.01%	320

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Firestone Capital Management's IONS Position: Q4 2021 in Review

Firestone Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 250 shares — an estimated $10K sold.

Firestone Capital Management first reported a position in IONS in Q4 2019 and held it in 8 quarters. The position peaked at $15K in Q2 2020. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

Firestone Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Firestone Capital Management sold 250 Ionis Pharmaceuticals shares in Q4 2021, an estimated $10K.
Firestone Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 8 quarters.
Firestone Capital Management's Ionis Pharmaceuticals position peaked at $15K in Q2 2020.
340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Firestone Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.